Rhogam, also known as Rh immunoglobulin, is a specially developed blood product that can prevent an Rh-negative mother's antibodies from attacking the fetus's Rh-positive cells. Rh-negative women will receive RhIg around the 28th week of pregnancy or at the time of an amniocentesis.
An injection of a naturally occurring blood product that almost always prevents the mother from producing antibodies against Rh-positive cells
An injection given to Rh-negative women to minimize the problems associated with Rh incompatibilities between the mother and newborn.
Ig6 directed against Rh positive antigens. Rhogam is indicated for an Rh negative infant, and an Rh negative mother who is not immunized to the Rh positive antigens.
The immunoglobulin, very similar to IVIg, that is given to Rh negative women carrying Rh positive infants to prevent her body from developing an immunity against the babies red blood cells.
an immunization given to Rh-negative women after a miscarriage, stillbirth, or live birth to prevent production of antibodies in any Rh-positive babies they may have in future pregnancies.
A medicine which was injected into pregnant women to avoid specific pregnancy complications. RhoGAMĀ® used to contain thimerosal, which some suspect is related to the development of autism.
Medication given to an RH negative mom to prevent complications with the RH factor for future pregnancies; administered at 28 weeks and within the first 72 hours after delivery if the baby is RH positive; also given after a miscarriage or abortion.
Medication given to prevent isoimmunization, given during pregnancy if an Rh- mother is carrying an Rh+ baby. See also Rhesus Factor.
(Rh Immune Gobulin) [ ro'gam] - A medication given to Rh-negative women during pregnancy to prevent Rh-incompatibility problems in later pregnancy. [see Rh-typing
Rh immunoglobulin (RhIg), also known as RhoGAM, is a specially developed blood product that can prevent an Rh-negative mother's antibodies from being able to react to Rh-positive cells. Women who've been diagnosed will receive RhIg around the 28th week of pregnancy and a second dose within 72 hours after delivery.